SG Americas Securities’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,808
| Closed | -$32K | – | 3446 |
|
|
2021
Q4 | $32K | Sell |
1,808
-2,359
| -57% | -$70.7K | ﹤0.01% | 3231 |
|
|
2021
Q3 | $154K | Buy |
4,167
+1,442
| +53% | +$64K | ﹤0.01% | 3415 |
|
|
2021
Q2 | $162K | Buy |
2,725
+1,093
| +67% | +$66.2K | ﹤0.01% | 2432 |
|
|
2021
Q1 | $109K | Buy |
1,632
+760
| +87% | +$59.5K | ﹤0.01% | 3041 |
|
|
2020
Q4 | $53K | Buy |
+872
| New | +$59.5K | ﹤0.01% | 3137 |
|
|
2020
Q3 | – | Sell |
-8,318
| Closed | -$520K | – | 3458 |
|
|
2020
Q2 | $520K | Buy |
8,318
+6,580
| +379% | +$383K | ﹤0.01% | 2061 |
|
|
2020
Q1 | $92K | Buy |
1,738
+517
| +42% | +$51.3K | ﹤0.01% | 3038 |
|
|
2019
Q4 | $148K | Sell |
1,221
-6,061
| -83% | -$871K | ﹤0.01% | 2700 |
|
|
2019
Q3 | $1.32M | Sell |
7,282
-48,809
| -87% | -$6.88M | 0.01% | 1232 |
|
|
2019
Q2 | $7.29M | Buy |
56,091
+46,258
| +470% | +$8.29M | 0.05% | 384 |
|
|
2019
Q1 | $2.39M | Buy |
+9,833
| New | +$2.6M | 0.02% | 753 |
|
|
2018
Q2 | – | Sell |
-403
| Closed | -$98K | – | 3552 |
|
|
2018
Q1 | $98K | Sell |
403
-1,678
| -81% | -$471K | ﹤0.01% | 2978 |
|
|
2017
Q4 | $628K | Sell |
2,081
-20
| -1% | -$5.57K | 0.01% | 1697 |
|
|
2017
Q3 | $556K | Sell |
2,101
-3
| -0.1% | -$867 | ﹤0.01% | 1758 |
|
|
2017
Q2 | $554K | Buy |
+2,104
| New | +$527K | 0.01% | 1795 |
|
|
2017
Q1 | – | Sell |
-381
| Closed | -$110K | – | 3568 |
|
|
2016
Q4 | $110K | Sell |
381
-22
| -5% | -$6.82K | ﹤0.01% | 2808 |
|
|
2016
Q3 | $137K | Buy |
+403
| New | +$147K | ﹤0.01% | 2804 |
|
|
2016
Q2 | – | Sell |
-444
| Closed | -$142K | – | 2986 |
|
|
2016
Q1 | $142K | Buy |
+444
| New | +$151K | ﹤0.01% | 2403 |
|
|
2015
Q4 | – | Sell |
-661
| Closed | -$194K | – | 2995 |
|
|
2015
Q3 | $194K | Buy |
661
+436
| +194% | +$155K | ﹤0.01% | 1483 |
|
|
2015
Q2 | $89K | Buy |
+225
| New | +$79.4K | ﹤0.01% | 2397 |
|
|
2014
Q4 | – | Sell |
-301
| Closed | -$70K | – | 3368 |
|
|
2014
Q3 | $70K | Sell |
301
-361
| -55% | -$90.9K | ﹤0.01% | 2436 |
|
|
2014
Q2 | $146K | Buy |
+662
| New | +$147K | ﹤0.01% | 2195 |
|
|
2013
Q4 | – | Sell |
-309
| Closed | -$45K | – | 3016 |
|
|
2013
Q3 | $45K | Buy |
309
+94
| +44% | +$11.4K | ﹤0.01% | 2807 |
|
|
2013
Q2 | $33K | Buy |
+215
| New | +$29.5K | ﹤0.01% | 2214 |
|
Other funds holding TXMD
CWG
RCMNY
SG Americas Securities's TXMD Position: Q1 2022 in Review
SG Americas Securities sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 1,808 shares — an estimated $32K sold.
SG Americas Securities first reported a position in TXMD in Q2 2013 and held it in 24 quarters. The position peaked at $7.29M in Q2 2019. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.
- SG Americas Securities reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
- SG Americas Securities sold 1,808 TherapeuticsMD shares in Q1 2022, an estimated $32K.
- SG Americas Securities first reported a position in TherapeuticsMD in Q2 2013 and held it in 24 quarters.
- SG Americas Securities's TherapeuticsMD position peaked at $7.29M in Q2 2019.
- 124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.
Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.